Kinsale Capital Group Inc. Purchases 2,231 Shares of Humana Inc. (NYSE:HUM)

Kinsale Capital Group Inc. increased its stake in Humana Inc. (NYSE:HUM) by 29.8% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 9,715 shares of the insurance provider’s stock after purchasing an additional 2,231 shares during the quarter. Kinsale Capital Group Inc.’s holdings in Humana were worth $3,630,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the stock. Coldstream Capital Management Inc. raised its holdings in Humana by 52.7% in the 2nd quarter. Coldstream Capital Management Inc. now owns 2,606 shares of the insurance provider’s stock worth $974,000 after purchasing an additional 899 shares during the period. Gryphon Financial Partners LLC bought a new position in Humana in the 2nd quarter worth $625,000. Mawer Investment Management Ltd. raised its holdings in Humana by 59.0% in the 2nd quarter. Mawer Investment Management Ltd. now owns 38,302 shares of the insurance provider’s stock worth $14,312,000 after purchasing an additional 14,213 shares during the period. Daiwa Securities Group Inc. raised its holdings in Humana by 8.4% in the 2nd quarter. Daiwa Securities Group Inc. now owns 13,154 shares of the insurance provider’s stock worth $4,915,000 after purchasing an additional 1,022 shares during the period. Finally, Balentine LLC bought a new position in Humana in the 2nd quarter worth $319,000. 92.38% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on HUM shares. Morgan Stanley assumed coverage on Humana in a report on Monday, June 24th. They issued an “equal weight” rating and a $374.00 target price on the stock. Robert W. Baird assumed coverage on Humana in a research note on Thursday, May 30th. They issued a “neutral” rating and a $374.00 price target for the company. Deutsche Bank Aktiengesellschaft increased their price target on Humana from $341.00 to $349.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. JPMorgan Chase & Co. increased their price target on Humana from $332.00 to $396.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 21st. Finally, Bank of America increased their price target on Humana from $342.00 to $376.00 and gave the stock a “neutral” rating in a research note on Monday, May 20th. Thirteen analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $398.70.

Humana Stock Up 0.8 %

Shares of NYSE:HUM opened at $346.42 on Wednesday. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.70. Humana Inc. has a 12 month low of $298.61 and a 12 month high of $530.54. The company has a 50-day moving average price of $366.51 and a 200 day moving average price of $347.37. The company has a market cap of $41.71 billion, a price-to-earnings ratio of 21.57, a PEG ratio of 2.80 and a beta of 0.50.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, beating analysts’ consensus estimates of $5.89 by $1.07. Humana had a net margin of 1.53% and a return on equity of 16.12%. The firm had revenue of $29.54 billion during the quarter, compared to the consensus estimate of $28.52 billion. During the same quarter last year, the firm earned $8.94 EPS. The firm’s revenue for the quarter was up 10.4% compared to the same quarter last year. As a group, equities research analysts predict that Humana Inc. will post 16 earnings per share for the current year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Monday, September 30th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.02%. The ex-dividend date of this dividend is Monday, September 30th. Humana’s dividend payout ratio (DPR) is currently 22.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.